title: Mucosal leishmaniasis in Brazil.
abstract: The clinical diagnosis and laboratory identification of Leishmania braziliensis braziliensis, a parasitic disease affecting the upper aerodigestive tract, is difficult. A retrospective computer-assisted analysis of patient records was done after examination of 58 patients with mucosal leishmaniasis in an endemic area of L. braziliensis braziliensis in Bahia, Brazil during January 1987. Biopsies of clinically active and clinically inactive mucosal patients were examined for parasites using routine hematoxylin and eosin histopathology and a new technique for rapid detection of Leishmania amastigotes using a genus-specific indirect immunofluorescent assay. No amastigotes were found in specimens from seven patients with clinically inactive mucosal disease using immunofluorescent monoclonal assay techniques, whereas specimens from seven out of 14 patients with clinically active mucosal disease were positive. These results suggest that the immunofluorescent antibody technique is markedly superior in identifying the intracellular amastigote in tissue sections of mucosal biopsies when compared to histopathology techniques or with other standard tests done in rural areas of Brazil. Various clinical and laboratory test data of the entire group of patients were examined and the efficacy of treatment evaluated. The median interval of time noted between cutaneous and mucosal disease was 4.5 years. Relapse was noted in 31% of patients treated with a low dose of meglumine antimoniate (10 mg per kg of body weight). Patients treated with a high dose of meglumine antimoniate (20 mg per kg of body weight) had a relapse rate of 27.3%. A chi-square statistical analysis revealed no significant difference (chi 2 = 0.049) between the two groups. Patients were considered cured if mucosal granulations were clinically absent after 4.6 years.
authors.affiliation: Otolaryngology/Head and Neck Surgery Service, Walter Reed Army Medical Center, Washington, DC 20307-5001.
authors.forename: J T
authors.initials: JT
authors.lastname: Zajtchuk
authors.forename: J D
authors.initials: JD
authors.lastname: Casler
authors.forename: E M
authors.initials: EM
authors.lastname: Netto
authors.forename: M
authors.initials: M
authors.lastname: Grogl
authors.forename: R C
authors.initials: RC
authors.lastname: Neafie
authors.forename: C R
authors.initials: CR
authors.lastname: Hessel
authors.forename: A V
authors.initials: AV
authors.lastname: de Magalhaes
authors.forename: P D
authors.initials: PD
authors.lastname: Marsden
mesh_terms: D001938:Brazil; D005455:Fluorescent Antibody Technique; D006801:Humans; D007897:Leishmaniasis, Mucocutaneous / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D010038:Otorhinolaryngologic Diseases / Q000175:diagnosis / Q000473:pathology / Q000628:therapy